ESR1 Mutations Are Not a Common Mechanism of Endocrine Resistance in Patients With Estrogen Receptor–Positive Breast Cancer Treated With Neoadjuvant Aromatase Inhibitor Therapy

por Reinert, Tomás, Ramalho, Susana, de Vasconcelos, Vivian Castro Antunes, Silva, Leonardo Roberto, da Silva, Ana Elisa Ribeiro, de Andrade, Camila Annicchino, Kraft, Maria Beatriz de Paula Leite, Coelho, Guilherme Portela, Mandelli, Jovana, Binotto, Monique, Cabello, Cesar, de Paiva Silva, Geisilene Russano, Bines, José, Barrios, Carlos H., Ellis, Matthew J., Graudenz, Marcia Silveira
Publicado 2020